Back
Stoke Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
27
STOK
Stoke Therapeutics
Last Price:
$11.68
Seasonality Move:
1.92%
Sell
19
NBY
NovaBay Pharmaceuticals
Last Price:
$0.53
Seasonality Move:
-0.66%
Sell
27
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy, Sell or Hold?
-
The current Stoke Therapeutics [STOK] share price is $11.68. The Score for STOK is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
STOK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
STOK Stock Price Chart
What is Stoke Therapeutics's stock price today?
-
The Stoke Therapeutics share price today is $11.68Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STOK is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.53The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
STOK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 44.25 | Sell |
Chaikin Money Flow: | 796966 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.4 - 12.76) | Sell |
Bollinger Bands (100): | (11.97 - 14.39) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 39.44 | Sell |
Chaikin Money Flow: | 514099 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.53 - 0.67) | Sell |
Bollinger Bands (100): | (0.49 - 0.69) | Sell |
STOK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.97 | Sell |
20-day SMA: | 12.2 | Sell |
50-day SMA: | 12.44 | Sell |
200-day SMA: | 12.93 | Sell |
8-day EMA: | 11.89 | Sell |
20-day EMA: | 12.18 | Sell |
50-day EMA: | 12.5 | Sell |
200-day EMA: | 12.12 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.54 | Sell |
20-day SMA: | 0.57 | Sell |
50-day SMA: | 0.63 | Sell |
200-day SMA: | 1.88 | Sell |
8-day EMA: | 0.54 | Sell |
20-day EMA: | 0.57 | Sell |
50-day EMA: | 0.64 | Sell |
200-day EMA: | 4.7 | Sell |
Stoke Therapeutics Earnings Growth & STOK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.50 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Stoke Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |